Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)

Blood

Volumn 90, Issue 4, 1997, Pages 1501-1507

  Citarella, Franca ^a   Felici, Angelina ^b   Brouwer, Mieke ^b   Wagstaff, John ^b   Fantoni, Antonio ^b   Hack, C Erik ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BLOOD CLOTTING FACTOR 12; FIBRINOGEN; INTERLEUKIN 2; MESSENGER RNA; PREALBUMIN; PREKALLIKREIN; RECOMBINANT INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIVER; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS;

EID: 0030761483     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1501.1501_1501_1507     Document Type: Article

References (67)

1. Cochrane CG, Griffin JH: The biochemistry and pathophysiology of the contact system of plasma. Adv lmmunol 33:241, 1982
2. Colman RW: Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest 73:1249, 1984
3. Saito H: Contact factors in health and disease. Thromb Haemost 13:36, 1987
4. Kaplan AP, Silverberg M: The coagulation-kinin pathway of human plasma. Blood 70:1, 1987
5. Kozin F, Cochrane CG: The contact activation system of plasma: Biochemistry and pathophysiology, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1988, p 101
6. Gordon EM, Gallagher C, Johnson RT, Blossey BK, Ilan J: Hepatocytes express blood coagulation factor XII (Hageman factor). J Lab Clin Med 115:463, 1990
7. Nuijens JH, Huijbregts CCM, Eerenberg AJM, Abbink JJ, Strack van Schijndel RJM, Felt-Bersma RJF, Thijs LG, Hack CE: Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 72:1841, 1988
8. Koj A: Definition and classification of acute-phase proteins, in Gordon AH, Koj A (eds): The Acute-Phase Response to Injury and Infection. Amsterdam, The Netherlands, Elsevier, 1985, p 139
9. Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74, 1994
10. Castell JV. Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich P: Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179, 1990
11. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621, 1990
12. Kushner I, Mackiewicz A: Acute phase response, in Mackiewicz A, Kushner I, Baumann H (eds): Acute Phase Proteins. Boca Raton, FL, CRC, 1996, p 4
13. Aldred AR, Schreiber G: The negative acute phase proteins, in Mackiewicz A, Kushner I, Baumann H (eds): Acute Phase Proteins. Boca Raton, FL, CRC, 1996, p 21
14. Brakenhoff JPJ, De Groot ER, Evers RF, Pannekoek H, Aarden LA: Molecular cloning and expression of hybridoma growth factor in E. coli. J Immunol 139:4116, 1987
15. Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA: Interleukin-6 is involved in interleukin-1-induced activities. Eur J Immunol 18:957, 1988
16. Helle M, Boeije L, Aarden LA: Functional discrimination between interleukin-6 and interleukin-1. Eur J Immunol 18:1535, 1988
17. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis from human monocytes. J Immunol Methods 95:99, 1986
18. Citarella F, Ravon DM, Pascucci B, Felici A, Fantoni A, Hack CE: Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces. Eur J Biochem 238:240, 1996
19. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
20. Citarella F, Aiuti A, La Porta C, Russo G, Pietropaolo C, Rinaldi M, Fantoni A: Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains. Eur J Biochem 208:23, 1992
21. Hack CE, Wagstaff J, Strack van Schijndel RJM, Eerenberg AJM, Pinedo HM, Thijs LG, Nuijens JH: Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: Implications for septic shock. Thromb Haemost 65:497, 1991
22. Thijs LG, Hack CE, Strack van Schijndel RJM, Nuijens JH, Wolbink GJ, Eerenberg-Belmer AJM, Vall van der H, Wagstaff J: Activation of the complement system during immunotherapy with recombinant interleukin-2: Relation to the development of side effects. J Immunol 144:2419, 1990
23. Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis b surface antigen. Science 209:497, 1980
24. Ganapathi MK, May LT, Schultz D, Brabenec A, Weinstein J, Sehgal PB, Kushner I: Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepotoma cell lines. Biochem Biophys Res Commun 157:271, 1988
25. Perlmutter DH, May LT, Sehgal PB: Interferon β2/interleukin-6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest 84:138, 1989
26. Gauldie J, Richards C, Harnish D, Lansdorp PM, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251, 1987
27. Darlington GJ, Wilson DR, Lachman LB: Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 103:787, 1986
28. Baumann H, Richards C, Gauldie J: Interactions among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 139:4122, 1987
29. Bartalena L, Farsetti A, Flink IL, Robbins J: Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (HepG2) cells. Mol Endocrinol 6:935, 1992
30. Gauldie J, Sauder DN, McAdams KPWJ, Dinarello CA: Purified interleukin-1 (IL-1) from human monocytes stimulates acute-phase protein synthesis by rodent hepatocytes in vitro. Immunology 60:203, 1987
31. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR: Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 78:1349, 1986
32. Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC: Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232:347, 1988
33. Moshage HJ, Roelofs HMJ, van Pelt JF, Hazenberg BPC, van Leeuwen MA, Limburg PC, Aarden LA, Yap SH: The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 155:112, 1988
34. Castell JV, Gómez-Lechón MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237, 1989
35. Baumann H, Onorato V, Gauldie J, Jahreis GP: Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J Biol Chem 262:9756, 1987
36. Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT: Regulation of the acute phase and immune responses in viral disease. J Exp Med 167:1951, 1988
37. Yap SH, Moshage HJ, Hazenberg BPC, Roelofs HMJ, Bijzet J, Limburg PC, Aarden LA, van Rijswijk MH: Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta Mol Cell Res 1091:405, 1991
38. Gauldie J, Northemann W, Fey GH: IL-6 functions as an exocrine hormone in inflammation hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 144:3804, 1990
39. Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 162:930, 1985
40. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC: Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 18:717, 1988
41. Marinkovic S, Jahreis GP, Wong GG, Baumann H: IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808, 1989
42. Birch HE, Schreiber G: Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem 261:8077, 1986
43. Morrone G, Ciliberto G, Oliviero S, Arcones R, Dente L, Content J, Cortese R: Recombinant interleukin 6 regulates transcriptional activation of a set of human acute phase genes. J Biol Chem 263:12554, 1988
44. Qian X, Samadani U, Porcella A, Costa RH: Decreased expression of hepatocyte nuclear factor 3α during the acute-phase response influences transthyretin gene transcription. Mol Cell Biol 15:1364, 1995
45. Auge-Gouillou C, Petropoulos I, Zakin MM: Liver-enriched HNF-3α and ubiquitous factors interact with the human transferrin gene enhancer. FEBS Lett 323:4, 1993
46. Costa RH, Grayson DR, Darnell JE Jr: Multiple hepatocyte-enriched nuclear factor function in the regulation of transthyretin and α1-antitrypsin genes. Mol Cell Biol 9:1415, 1989
47. Citarella F, Misiti S, Felici A, Aiuti A, La Porta C, Fantoni A: The 5' sequence of human factor XII gene contains transcription regulatory elements typical of liver specific, estrogen-modulated genes. Biochim Biophys Acta 1172:197, 1993
48. Overdier DG, Porcella A, Costa RH: The DNA-binding specifity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino acid residues adiacent to the recognition helix. Mol Cell Biol 14:2755, 1994
49. Ratnoff OD, Busse RJ Jr, Sheon RP: The demise of John Hageman. N Engl J Med 279:760, 1968
50. Goodnough LT, Saito H, Ratnoff OD: Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine 62:248, 1983
51. Lammle B, Wuillemin WA, Huber I, Krauskopf M, Zürcher C, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency. A study on 74 subjects from 14 Swiss families. Thromb Haemost 65:117, 1991
52. Kluft C, Dooijewaard G, Emeis JJ: Role of the contact system in fibrinolysis. Thromb Haemost 13:50, 1987
53. Levi M, Hack CE, De Boer JP, Brandjes DPM, Büller HR, ten Cate WJ: Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 88:1155, 1991
54. Jansen PM, Pixley RA, Brouwer M, de Jong IW, Chang ACK, Hack CE, Taylor FB Jr, Colman RW: Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 6:2337, 1996
55. Amrani DL: Regulation of fibrinogen biosynthesis: Glucocorticoid and interleukin-6 control. Blood Coagul Fibrinolysis 1:443, 1990
56. Andus T, Geiger T, Hirano T, Northoff H, Ganter U, Bauer J, Kishimoto T, Heinrich PC: Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-β32) regulates β-fibrinogen and albumin mRNA levels in FAO-9 cells. FEBS Lett 221:18, 1987
57. Evans E, Courtois GM, Kilian PL, Fuller GM, Crabtree GR: Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters. J Biol Chem 262:10850, 1987
58. Princen JMG, Nieuwenhuizen W, Mol-Backx GPBM, Yap SH: Direct evidence of transcriptional control of fibrinogen and albumin synthesis in rat liver during the acute phase response. Biochem Biophys Res Commun 102:717, 1981
59. De Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JWJ, van Mourik JA, Hack CE: PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines. Evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 65:181, 1991
60. Suffredini AF, Harpel PC, Parillo JE: Promotion and subsequent inhibition of plasminogen activator after administation of intravenous endotoxin to normal subjects. N Engl J Med 18:1165, 1989
61. Juhan-Vague I, Aillaud MF, de Cock F, Philip-Joet C, Arnaud C, Serradimigni A, Collen D: The fast-acting inhibitor of tissue plasminogen activator is an acute phase reactant protein, in Davidson JF, Donati MB, Coccheri S (eds): Progress in Fibrinolysis. Edinburgh, UK, Churchill-Livingstone, 1985, p 146
62. Kluft C, Verheijen JH, Jie AFH, Rijken DC, Preston FE. Sue-Ling HM, Jespersen J, Aasen AO: The postoperative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast-acting inhibitor of tisue-type plasminogen activator after trauma. Scand J Clin Lab Invest 45:605, 1985
63. Medina R, Socher SH, Han JH, Friedman PA: Interleukin-1, endotoxin or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells. Thromb Res 54:41, 1989
64. Emeis JJ, Kooistra T: Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 163:1260, 1986
65. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA: Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 163:1595, 1986
66. Van Hinsbergh VWM, Kooistra T, van den Berg EA, Princen HMG, Fiers W, Emeis JJ: Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and rats in vivo. Blood 72:1467, 1988
67. Quax PHA, Van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, Van Berkel TJC, Kuiper J, Emeis JJ: Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 265:15560, 1990